Lawrence True
Lawrence True
Professor of Pathology
Verified email at uw.edu
Title
Cited by
Cited by
Year
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
33782010
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
24452015
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
16222015
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth
RB Montgomery, EA Mostaghel, R Vessella, DL Hess, TF Kalhorn, ...
Cancer research 68 (11), 4447-4454, 2008
14732008
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
9162009
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Y Sun, J Campisi, C Higano, TM Beer, P Porter, I Coleman, L True, ...
Nature medicine 18 (9), 1359-1368, 2012
6482012
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer
EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ...
Cancer research 67 (10), 5033-5041, 2007
5792007
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2
B Lin, C Ferguson, JT White, S Wang, R Vessella, LD True, L Hood, ...
Cancer research 59 (17), 4180-4184, 1999
5671999
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy …
WU Shipley, KA Winter, DS Kaufman, WR Lee, NM Heney, WR Tester, ...
Journal of Clinical Oncology 16 (11), 3576-3583, 1998
5411998
Expression profiling reveals hepsin overexpression in prostate cancer
JA Magee, T Araki, S Patil, T Ehrig, L True, PA Humphrey, WJ Catalona, ...
Cancer research 61 (15), 5692-5696, 2001
4922001
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
A Kumar, I Coleman, C Morrissey, X Zhang, LD True, R Gulati, R Etzioni, ...
Nature medicine 22 (4), 369-378, 2016
4862016
Human cancers express a mutator phenotype
JH Bielas, KR Loeb, BP Rubin, LD True, LA Loeb
Proceedings of the National Academy of Sciences 103 (48), 18238-18242, 2006
4162006
Multicolor quantum dots for molecular diagnostics of cancer
AM Smith, S Dave, S Nie, L True, X Gao
Expert review of molecular diagnostics 6 (2), 231-244, 2006
4062006
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease
D Di Vizio, J Kim, MH Hager, M Morello, W Yang, CJ Lafargue, LD True, ...
Cancer research 69 (13), 5601-5609, 2009
3532009
A causal role for ERG in neoplastic transformation of prostate epithelium
O Klezovitch, M Risk, I Coleman, JM Lucas, M Null, LD True, PS Nelson, ...
Proceedings of the National Academy of Sciences 105 (6), 2105-2110, 2008
3402008
Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors
HL Kenerson, LD Aicher, LD True, RS Yeung
Cancer research 62 (20), 5645-5650, 2002
3332002
Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors
SN Agoff, LW Lamps, AT Philip, MB Amin, RA Schmidt, LD True, AL Folpe
Modern Pathology 13 (3), 238-242, 2000
3322000
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
W Tester, R Caplan, J Heaney, P Venner, R Whittington, R Byhardt, ...
Journal of clinical oncology 14 (1), 119-126, 1996
3221996
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
MP Roudier, LD True, CS Higano, H Vesselle, W Ellis, P Lange, ...
Human pathology 34 (7), 646-653, 2003
3202003
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
L True, I Coleman, S Hawley, CY Huang, D Gifford, R Coleman, TM Beer, ...
Proceedings of the National Academy of Sciences 103 (29), 10991-10996, 2006
3162006
The system can't perform the operation now. Try again later.
Articles 1–20